Skip to content

A randomized controlled multicenter clinical trial of Xinxinfu combined with Qiangxin Fang in the treatment of coronary heart disease complicated with cardiac insufficiency

A randomized controlled multicenter clinical trial of Xinxinfu combined with Qiangxin Fang in the treatment of coronary heart disease complicated with cardiac insufficiency

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037399
Enrollment
Unknown
Registered
2020-08-28
Start date
2020-10-31
Completion date
Unknown
Last updated
2020-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease

Interventions

Sponsors

Shanghai Municipal Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) those who meet the diagnostic criteria of coronary heart disease, chronic heart failure and Yang deficiency and Blood Stasis Syndrome of TCM; (2) those aged 18 to 75; (3) those who have not taken any other proprietary Chinese medicine or decoction for treating coronary heart disease with heart failure within 2 weeks; (4) the patient informed and consented to the study and has signed the informed consent form, in line with our hospital ethics committee certification, all treatment and examination are informed consent of patients or family members.

Exclusion criteria

Exclusion criteria: (1) with Cardiogenic shock, severe ventricular Arrhythmia, complete atrioventricular block, obstructive cardiomyopathy, severe valvular heart disease, severe pericardial disease; (2) allergic to or allergic to multiple drugs; (3) suffering from serious diseases such as liver, kidney, brain, blood system and infection; (4) non-cooperative patient or patient with mental disease; (5) hypertension, diabetes not under control or unstable control; (6) inability to work with researchers due to disability or mental illness.

Design outcomes

Primary

MeasureTime frame
Assessment of cardiac function;Assessment of cardiac function;Pulmonary function assessment;

Countries

China

Contacts

Public ContactLai Zhikun

Shanghai Municipal Hospital of Traditional Chinese Medicine

laizhikun1222@163.com+86 18817339800

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026